DF
RMD icon

Dunhill Financial’s ResMed RMD Stock Holding History

Dunhill Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55K Sell
11
-3
-21% -$748 ﹤0.01% 745
2025
Q4 		$3.29K Buy
14
+2
+17% +$511 ﹤0.01% 664
2025
Q3 		$3.24K Buy
12
+1
+9% +$273 ﹤0.01% 619
2025
Q2 		$3.04K Sell
11
-25
-69% -$5.96K ﹤0.01% 621
2025
Q1 		$8.04K Sell
36
-2
-5% -$467 ﹤0.01% 462
2024
Q4 		$8.72K Buy
38
+7
+23% +$1.69K ﹤0.01% 420
2024
Q3 		$7.52K Buy
31
+17
+121% +$3.8K ﹤0.01% 462
2024
Q2 		$2.74K Buy
14
+3
+27% +$609 ﹤0.01% 509
2024
Q1 		$2.23K Buy
11
+2
+22% +$366 ﹤0.01% 473
2023
Q4 		$1.62K Buy
+9
New +$1.38K ﹤0.01% 495

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dunhill Financial's RMD Position: Q1 2026 in Review

Dunhill Financial reduced its ResMed (RMD) stake by 21% in Q1 2026, selling an estimated $748 and leaving 11 shares worth $2.55K. The position accounts for ﹤0.01% of the portfolio, ranked #745.

Dunhill Financial first reported a position in RMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.72K in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Dunhill Financial held 11 shares of ResMed worth $2.55K as of Q1 2026.
  • Dunhill Financial sold 3 ResMed shares in Q1 2026, an estimated $748.
  • ResMed made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #745 holding.
  • Dunhill Financial first reported a position in ResMed in Q4 2023 and has held it in 10 quarters since.
  • Dunhill Financial's ResMed position peaked at $8.72K in Q4 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.